We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$90.5B
1-Year Est. Return
33.95%
This Fund
S&P 500
This Quarter
Est. Return
+17.08%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$13.4B
AUM Growth
+$5.98B
(+81%)
Cap. Flow
+$3.16B
Cap. Flow
% of AUM
23.6%
Top 10 Holdings %
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.46B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$437M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
Amazon
AMZN
|
+$185M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$51.4M |
| 2 |
Lowe's Companies
LOW
|
+$45.3M |
| 3 |
CVS Health
CVS
|
+$37.3M |
| 4 |
Eli Lilly
LLY
|
+$32.7M |
| 5 |
Southern Company
SO
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.4% |
| 2 | Technology | 14.71% |
| 3 | Consumer Discretionary | 11.73% |
| 4 | Healthcare | 8.95% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Regency Centers
REG
$13.4B
| $977K | 0.01% |
21,424
-26,837
| -56% | -$1.15M |
|
|
QVCGA
1352
DELISTED
QVC Group Inc Series A
QVCGA
| $977K | 0.01% |
+1,781
| New | +$802K |
|
|
YMAB
1353
DELISTED
Y-mAbs Therapeutics
YMAB
| $976K | 0.01% |
19,715
+4,180
| +27% | +$193K |
|
1354
Black Diamond Therapeutics
BDTX
$111M
| $975K | 0.01% |
+30,434
| New | +$1,000K |
|
1355
iRhythm Holdings
IRTC
$3.68B
| $974K | 0.01% |
4,107
+2,685
| +189% | +$612K |
|
1356
UFP Industries
UFPI
$4.37B
| $974K | 0.01% |
17,537
-3,936
| -18% | -$216K |
|
1357
Opko Health
OPK
$1.21B
| $972K | 0.01% |
246,102
-719,543
| -75% | -$3M |
|
1358
iQIYI
IQ
$1.06B
| $970K | 0.01% |
+55,498
| New | +$1.25M |
|
1359
Frontdoor
FTDR
$5.48B
| $965K | 0.01% |
19,222
-4,709
| -20% | -$215K |
|
1360
Fastly Inc
FSLY
$3.91B
| $962K | 0.01% |
11,016
-52,643
| -83% | -$4.64M |
|
1361
Mustang Bio
MBIO
$3.71M
| $961K | 0.01% |
339
+182
| +116% | +$435K |
|
1362
Synaptics
SYNA
$3.62B
| $961K | 0.01% |
9,970
-76,078
| -88% | -$6.19M |
|
1363
Forward Air
FWRD
$521M
| $960K | 0.01% |
+12,492
| New | +$866K |
|
1364
Stepan Co
SCL
$1.43B
| $960K | 0.01% |
8,043
+2,243
| +39% | +$264K |
|
1365
Cerence
CRNC
$369M
| $958K | 0.01% |
+9,535
| New | +$711K |
|
1366
Encompass Health
EHC
$12.1B
| $957K | 0.01% |
14,542
-136,185
| -90% | -$8.01M |
|
1367
Qiagen
QGEN
$9.16B
| $956K | 0.01% |
+17,054
| New | +$910K |
|
|
MDC
1368
DELISTED
M.D.C. Holdings, Inc.
MDC
| $955K | 0.01% |
21,225
-65,841
| -76% | -$2.93M |
|
1369
Acadia Healthcare
ACHC
$2.68B
| $953K | 0.01% |
18,954
+5,533
| +41% | +$221K |
|
1370
8x8 Inc
EGHT
$261M
| $951K | 0.01% |
27,589
-120,742
| -81% | -$2.59M |
|
1371
Phathom Pharmaceuticals
PHAT
$627M
| $949K | 0.01% |
+28,573
| New | +$1.16M |
|
1372
ScottsMiracle-Gro
SMG
$3.14B
| $947K | 0.01% |
4,756
-22,096
| -82% | -$3.79M |
|
|
ISBC
1373
DELISTED
Investors Bancorp, Inc.
ISBC
| $947K | 0.01% |
89,684
+48,109
| +116% | +$440K |
|
|
FISV
1374
CALL
Fiserv Inc
FISV
$26.2B
| $945K | 0.01% |
+8,300
| New | +$894K |
|
1375
Abercrombie & Fitch
ANF
$5.88B
| $944K | 0.01% |
46,356
-270,808
| -85% | -$4.96M |
|
Similar funds
VM
Squarepoint's Q4 2020 Portfolio in Review
As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Squarepoint deployed $3.16B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.
- Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
- Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
- Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
- Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
- Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
- Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.
Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.